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Non-cardiac surgery represents a major global public 
health burden,[1] with a postoperative mortality rate 
of 2 - 4%.[2,3] Surgery is cost-effective, however,[4] and 
a core component of health.[5] Surgical outcomes were 
well described in Europe in the European Surgical 
Outcomes Study (EuSOS).[3] These data cannot be extrapolated to 
South Africa (SA), as the country has a lower human development 
index than Europe and different population morbidity patterns. SA 
faces four simultaneous major epidemics: (i) poverty-related diseases; 
(ii) non-communicable diseases (NCDs); (iii) HIV and related 
diseases; and (iv) injury and violence.[6] In SA, perioperative outcome 
data are scarce.[7] The Global Burden of Disease Study[8] suggests 
a proportionally larger contribution of communicable diseases 
to perioperative mortality compared with Europe, and a lesser 
contribution of NCDs. The contribution of HIV to perioperative 
outcomes is unclear.[9]
The above provided the rationale to conduct a study similar to 
EuSOS in SA, known as the South African Surgical Outcomes Study 
(SASOS). The primary outcome was in-hospital mortality. Secondary 
outcomes included duration of hospital stay, rate of admission to 
critical care following surgery, and duration of critical care stay. In 
order to understand the proportional contribution of communicable 
diseases, NCDs and injuries to surgical outcomes, these variables 
were also added to the adopted EuSOS dataset. Risk factors associated 
with in-hospital mortality and critical care admissions were also 
explored.
Methods
This was a 7-day, SA national multicentre prospective observational 
cohort study of patients aged ≥16 years undergoing inpatient non-
cardiac surgery. The study was registered on ClinicalTrials.gov 
(NCT02141867).
Departments of anaesthesia, surgery, critical care and gynaecology 
affiliated to all the medical schools in SA agreed to participate. A 
sample of 50 participating hospitals was obtained by approaching 
all the hospitals in which training by these academic departments 
took place. Additional hospitals were recruited through professional 
contacts. All SA provinces were represented. Hospital-specific data 
were collected, including number of operating rooms and number 
and level of critical care beds. Ethics approval was obtained for all 
sites.
The ethics review board of each medical school (University of 
Cape Town, University of the Free State, University of KwaZulu-
Natal, University of Limpopo, University of Pretoria, Stellenbosch 
University, University of the Witwatersrand (Wits) and Walter 
Sisulu University) approved the study. For the majority of sites, a 
waiver of consent was approved. Wits and the Free State Provincial 
Administration stipulated that informed consent be required from 
all patients, with deferred consent for patients who could not 
give consent prior to surgery. Wits stipulated that only patients 
aged ≥18 years could consent to participate. The intention was 
to recruit all eligible patients in order to minimise data selection 
bias.
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Recruitment ran from 07h00 on 19 May 
2014 to 06h59 on 26 May. Eligible patients 
included all patients aged ≥16 years (with the 
exception of the Wits hospitals) undergoing 
elective or non-elective inpatient non-
cardiac surgery during the 7-day recruitment 
period. Exclusions were planned day surgery, 
cardiac surgery, radiological procedures not 
requiring anaesthesia, and obstetric patients. 
Recruitment preoperatively, and follow-up 
until discharge, were performed by local 
investigators. The study was censored at 
30 days postoperatively for patients still in 
hospital.
The EuSOS dataset was adopted with 
minor changes. The major deviation from 
the EuSOS protocol, as recommended by 
the EuSOS steering committee, was to 
censor the study at 30 days as opposed to 60 
days because most of the deaths in EuSOS 
occurred within 30 days of surgery.
The same potential risk factors as in 
EuSOS were collected for in-hospital 
mortality and critical care mortality, but 
the primary indication for surgery, based 
on the categories of communicable 
diseases, NCDs and injuries, was added. 
Neurosurgical patients were included. To 
ensure consistency in data definitions and 
interpretation, the principal investigators 
(BMB and TEM) made site visits to meet 
with local investigators and provide study 
educational material. The website provided 
educational support and a regularly updated 
‘frequently asked questions’ web page. The 
case report forms (CRFs) are available on the 
study website (www.sasos.co.za).
Data were collected on paper CRFs 
and were pseudoanonymised by unique 
numerical codes generated during data 
transcription onto an internet-based CRF. 
Each patient could only be identified on 
the electronic CRF by their numerical code. 
The co-ordinating study team could not 
trace data back to an individual patient 
without contact with the local team. Access 
to the data entry system was username 
and password protected. All electronic 
data transfer was encrypted using a secure 
protocol. The study was reported according 
to the STROBE statement.[10]
Statistical analysis
Based on expected surgical volumes 
submitted to the steering committee from 
the participating hospitals, we believed that 
it would be possible to generate a sample 
size close to 7 500 patients during a 7-day 
recruitment period. We assumed the same 
mortality rate as that for EuSOS (4%)[3] and 
an admission rate to critical care of half that 
in EuSOS (4% v. 8%, respectively). [3] We 
could therefore include up to 30 variables 
in logistical regression models for mortality 
and critical care admission.[11] The data 
collected were all part of routine clinical 
care. Categorical variables were described 
as proportions and compared using χ2 tests, 
Fisher’s exact tests, Pearson’s χ2 tests or χ2 
tests with Yates’s correction, as appropriate. 
Continuous variables were described as 
means and standard deviations (SDs) 
if normally distributed, or otherwise as 
medians and interquartile ranges (IQRs). 
Comparisons of continuous variables 
between groups were performed using 
unpaired t-tests or one-way analysis of 
variance, as appropriate. Univariate analysis 
was performed to test for risk factors 
associated with critical care admission and/
or in-hospital death.
Generalised linear mixed models using a 
logit link were used to identify independent 
risk factors for binary outcomes. These 
included one-level, hierarchical two-level 
and three-level models to account for the 
expected correlation in outcomes within 
hospitals and provinces. We used a three-
level generalised mixed model, with 
patients being at the first level, hospital 
at the second and province at the third. 
We excluded patients with missing values 
for potential risk predictors, and only used 
complete case analysis as <4% of the dataset 
was incomplete for a potential clinical 
risk predictor.[12] Results were reported 
as adjusted odds ratios (ORs) with 95% 
confidence intervals (CIs). All factors with a 
univariate association of p<0.05 were entered 
into the models. The exception was diabetes, 
which was not entered into the mortality 
model because we identified confounding 
between diabetes, American Society of 
Anesthesiologists (ASA) category and age. 
In the critical care admission regression, 
as nine of the 14 surgical categories had 
univariate associations with critical care 
admission, we entered a single surgical 
categorical variable into the regression. 
The average population-attributable risk 
(PAR) for variables associated with the 
outcomes was calculated[13] for a single-
level model. Univariate and multivariate 
statistical analyses were performed using 
Statistical Package for the Social Sciences 
(SPSS) version 21 (SPSS Inc., USA). R 
statistical software package version 3.0.2 
(R Foundation for Statistical Computing, 
Austria) was used to compute the PARs. All 
contingency table comparisons and unpaired 
t-tests between SASOS and EuSOS data were 
conducted using GraphPad Software Online 
Calculators (Graphpad Software Inc., USA).
Results
SASOS included 50 government-funded 
hospitals: 8 district hospi tals, 41 regional or 
tertiary hospitals and 1 specialised services 
hospital. These hospitals had a median of 
5 (IQR 4 - 8) operating rooms. Critical 
care units were available in 44/50 hospitals 
(88.0%). These units provided a median 
of 7 (IQR 4 -16) critical care beds, with a 
median of 6 (IQR 2 - 10) beds with access 
to mechanical ventilation and 3 (IQR 0 - 6) 
without mechanical ventilation.
The study recruitment is shown in 
the flow diagram in Fig. 1. The overall 
recruitment was 3 927/4 021 of eligible 
patients (97.7%), with 45/50 hospitals 
3 937 patients entered into database
8 duplicates removed
3 929 patients available for 
inclusion
2 missing outcome data
3 927 patients included in analysis
255 critical care admissions, 144 planned and 111 unplanned
Fig. 1. CONSORT diagram for survival analysis and critical care admission.
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Table 1. Description of cohort*
All patients
 (N=3 927)
Alive
(N=3 804)
Died
(N=123) OR (95% CI) p-value
Age (years), mean (SD) 43.5 (17.6) 43.3 (17.6) 52.1 (17.7) 1.03 (1.02 - 1.04) <0.001
Male, n (%) 1 994 (50.8) 1 923 (50.6) 71 (57.7) 1.33 (0.93 - 1.2) 0.12
Current smoker, n (%) 1 083 (28.2) 1 057 (28.4) 26 (23.0) 0.75 (0.48 - 1.12) 0.21
ASA category, n (%)
1 1 743 (44.7) 1 731 (45.8) 12 (9.8) Reference
2 1 347 (34.6) 1 318 (34.9) 29 (23.8) 3.18 (1.61 - 6.24) <0.001
3 663 (17.0) 623 (16.5) 40 (32.8) 9.26 (4.83 - 17.77) <0.001
4 131 (3.4) 94 (2.5) 37 (30.3) 56.78 (28.67 - 112.46) <0.001
5 14 (0.4) 10 (0.3) 4 (3.3) 57.70 (15.87 - 209.84) <0.001
Grade of surgery, n (%)
Minor 1 403 (36.1) 1 387 (36.8) 16 (13.2) Reference
Intermediate 1 672 (43.0) 1 627 (43.2) 45 (37.2) 2.40 (1.35 - 4.26) 0.003
Major 810 (20.8) 750 (19.9) 60 (49.6) 6.94 (3.97 - 6.94) <0.001
Urgency of surgery, n (%)
Elective 1 795 (45.8) 1 770 (46.7) 25 (20.3) Reference
Urgent 1 290 (33.0) 1 248 (32.9) 42 (34.1) 2.38 (1.45 - 3.93) 0.001
Emergency 830 (21.2) 774 (20.4) 56 (45.5) 5.12 (3.17 - 8.27) <0.001
Laparoscopic surgery, n (%) 159 (4.1) 159 (4.2) 0 (0.0) 0.01
Surgical specialty, n (%)
Orthopaedic 1 112 (28.4) 1 100 (29.0) 12 (9.8) 0.22 (0.11 - 0.45) <0.001
Breast 109 (2.8) 108 (2.8) 1 (0.8) 0.19 (0.03 - 1.41) 0.10
Gynaecology 525 (13.4) 523 (13.8) 2 (1.6) 0.08 (0.02 - 0.33) 0.001
Vascular 134 (3.4) 125 (3.3) 9 (7.3) 1.47 (0.67 - 3.24) 0.34
Upper GIT 154 (3.9) 136 (3.6) 18 (14.6) 2.70 (1.42 - 5.11) 0.002
Lower GIT 400 (10.2) 376 (9.9) 24 (19.5) 1.30 (0.73 - 2.33) 0.38
Hepatobiliary 88 (2.2) 84 (2.2) 4 (3.3) 0.97 (0.33 - 2.87) 0.96
Plastics 242 (6.2) 235 (6.2) 7 (5.7) 0.61 (0.26 - 1.43) 0.25
Urology 212 (5.4) 208 (5.5) 4 (3.3) 0.39 (0.13 - 1.14) 0.25
Kidney 13 (0.3) 13 (0.3) 0 (0.0) 0.52
Head and neck 222 (5.7) 216 (5.7) 6 (4.9) 0.57 (0.23 - 1.40) 0.22
Neurosurgery 133 (3.4) 122 (3.2) 11 (8.9) 1.84 (0.88 - 3.85) 0.11
Thoracic 65 (1.7) 64 (1.7) 1 (0.8) 0.32 (0.04 - 2.39) 0.32
Other 513 (13.1) 489 (12.9) 24 (19.5) Reference
Primary indication for surgery, n (%)
Non-communicable 1 881 (48.1) 1 832 (48.3) 49 (39.8) Reference
Injury 1 297 (33.1) 1 253 (33.1) 44 (35.8) 1.31 (0.87 - 1.99) 0.29
Infective 736 (18.8) 706 (18.6) 30 (24.4) 1.59 (1.00 - 2.52) 0.05
Comorbid disorder, n (%)
Coronary artery disease 160 (4.1) 152 (4.1) 8 (6.7) 1.71 (0.82 - 3.56) 0.16
Congestive heart failure 55 (1.4) 52 (1.4) 3 (2.5) 1.84 (0.57 - 5.98) 0.31
Diabetes mellitus (no insulin) 225 (5.8) 217 (5.8) 8 (6.7) 1.18 (0.57 - 2.44) 0.67
Diabetes mellitus with insulin therapy 171 (4.4) 160 (4.3) 11 (9.2) 2.29 (1.21 - 4.34) 0.01
Metastatic cancer 101 (2.6) 89 (2.4) 12 (10.1) 4.61 (2.45 - 8.69) <0.001
Cirrhosis 7 (0.2) 6 (0.2) 1 (0.8) 5.29 (0.63 - 44.27) 0.12
Stroke or TIA 55 (1.4) 47 (1.3) 8 (6.7) 5.68 (2.62 - 12.30) <0.001
COPD/asthma 240 (6.2) 230 (6.1) 10 (8.4) 1.40 (0.73 - 2.72) 0.31
HIV-positive/AIDS 509 (13.2) 498 (13.3) 11 (9.2) 0.67 (0.36 - 1.25) 0.67
GIT = gastrointestinal; TIA = transient ischaemic attack; COPD = chronic obstructive pulmonary disease.
*Data are mean (SD) or n (proportion). The denominator of the proportion is the number of cases that reported the risk factor. ORs were constructed for in-hospital mortality with univariate binary 
logistic regression analysis.
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(90.0%) submitting data on all eligible 
patients. The patient characteristics and 
univariate associations with in-hospital 
mortality are shown in Table 1. Of the 
patients, 131/3 927 (3.3%) had missing 
clinical risk predictor data for in-hospital 
mortality.
The in-hospital mortality rate was 
123/3  927 (3.1%; 95% CI 2.6 - 3.7). There 
were no deaths at the district hospitals 
(0/255) and 122/3 624 deaths (3.1%; 95% 
CI  2.5 - 3.7) at the regional and tertiary 
hospitals. The highest hospital mortality 
was 9.5%. The median duration of hospital 
stay was 3 days (IQR 1 - 6). The rate of 
postoperative admission to critical care 
was 255/3 927 (6.5%; 95% CI 5.7 - 7.3), 
with 144/3 927 (3.7%; 95% CI 3.1 - 4.3) 
admissions planned and 111/3 927 (2.8%; 
95% CI 2.3 - 3.3) unplanned; 111/255 
(43.5%) critical care admissions were 
un planned. More patients were admitted 
to critical care in the regional and tertiary 
hospitals (248/3 625, 6.8%) than in the 
district hospitals (7/255, 2.7%; p=0.008). 
Sixty-six of the patients who died (53.7%) 
were not admitted to critical care. Critical 
care mortality was 57/255 (22.4%). Patients 
who had un planned admissions to critical 
care had a signifi cantly higher mortality 
than those with planned admissions (37/111 
(33.3%) v. 20/144 (13.9%), respectively; 
p<0.001) (Fig. 2). The median duration of 
critical care stay was 3 days (IQR 1 - 7). 
The generalised linear model for in-hospital 
mortality and the associated PAR for inde-
pendent risk factors are shown in Table 2.
The univariate associations with critical 
care admissions are shown in Table 3. Of 
the patients, 132/3 927 (3.4%) had missing 
clinical risk predictor data for critical care 
admission. The generalised linear model for 
critical care admission and the associated 
PAR for independent risk factors are shown 
in Table 4.
Comparisons between the SASOS data 
and the EuSOS data[3] are shown in Table 5. 
The mortalities were not compared as the 
outcome durations were different, and we 
could not risk-adjust for the differences in 
comorbidities between the populations.
Discussion
Principal findings
The SASOS in-hospital mortality was 3.1%, 
with 6.5% of surgical patients having been 
admitted to a critical care unit. The median 
duration of hospital stay was 3 days (IQR 
1 - 6) and that of critical care 3 days (IQR 1 - 
7). Most surgery was urgent or emergency 
(2 120/3 915, 66.4%). Urgent and emergency 
surgery represented a significant PAR for 
mortality (25.5%; 95% CI 5.1 - 55.8) and 
critical care admission (23.7%; 95% CI 4.7 - 
51.4). Unplanned critical care admission 
had a significantly higher associated 
mortality than planned admission. The 
SASOS data suggest that NCDs (reflected by 
metastatic cancers and stroke) have a larger 
proportional contribution to mortality than 
communicable diseases and injuries.
When compared with the EuSOS data, 
SASOS patients were significantly younger 
and there were fewer non-communicable 
risk factors. The most common comorbidity 
was HIV infection, although it was not 
associated with in-hospital mortality. 
SASOS patients underwent significantly 
more urgent and emergency surgery 
(p<0.0001). Although SASOS patients had 
a significantly lower rate of critical care 
admissions than those in EuSOS (6.5%; 95% 
CI 5.7 - 7.3 v. 7.7%; 95% CI 7.5 - 8.0), they 
had significantly more unplanned critical 
care admissions (p<0.0001). SASOS patients 
spent longer in critical care than EuSOS 
patients (3  days; IQR 1 - 7 v. 1.2 days; 
IQR 0.9 - 3.6, respectively).
Strengths and weaknesses of SASOS
The strengths of this study are that it included 
all the government-funded, public sector, 
tertiary hospitals in SA, 41/74 (55.4%) of the 
government-funded regional hospitals, and 
50/410 (12.2%) of all government-funded 
hospitals.[14] SASOS is therefore possibly 
generalisable to government-funded regional 
and tertiary hospitals in SA.
By adopting the EuSOS protocol with 
minor modifications, SASOS provides 
data that are directly comparable with the 
EuSOS data and 28 European countries. 
This has important implications for 
generating consistent outcomes data for the 
Commission for Global Surgery. These are 
the first data from SA.
Table 2. Three-level generalised linear model for in-hospital mortality
OR* (95% CI) p-value
One-level PAR
% (95% CI)
Age (years) 1.02 (1.01 - 1.04) 0.001 NS
ASA category
1 Reference 39.3 (12.4 - 77.1)
2 2.95 (1.41 - 6.17) 0.004
3 5.18 (2.48 - 10.86) <0.001
4 22.09 (9.87 - 49.46) <0.001
5 15.51 (3.43 - 70.25) <0.001
Grade of surgery
Minor Reference 24.2 (4.2 - 53.9)
Intermediate 1.74 (0.94 - 3.24) 0.08
Major 3.21 (1.70 - 6.07) <0.001
Urgency of surgery
Elective Reference 25.5 (5.1 - 55.8)
Urgent 2.10 (1.17 - 3.75) 0.01
Emergency 2.53 (1.39 - 4.58) 0.002
Surgical specialty
Orthopaedic 0.20 (0.10 - 0.42) <0.001
Gynaecology 0.24 (0.06 - 1.03) 0.54
Upper GIT 2.14 (1.15 - 3.99) 0.02 3.6 (0.3 - 9.7)
Primary indication for surgery
Non-communicable Reference
Infective 1.89 (1.06 - 3.38) 0.03 NS
Injury 3.35 (1.87 - 6.02) <0.001 NS
Comorbid disorder
Metastatic cancer 2.96 (1.39 - 6.29) 0.01 2.2 (0.2 - 5.8)
Stroke or TIA 2.82 (1.09 - 7.32) 0.03 1.8 (0.1 - 4.7)
GIT = gastrointestinal; TIA = transient ischaemic attack; NS = not significant at a single-level regression.
*ORs were constructed for in-hospital mortality with a three-level generalised linear model.
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Furthermore, this is the first study that 
has addressed the proportional contribution 
of the burden of disease categories 
(communicable diseases, NCDs and injuries) 
to perioperative mortality. The independent 
risk factors for in-hospital mortality were 
similar to those in EuSOS, suggesting that 
these risk factors are globally consistent. 
These risk factors are dominated by NCDs. 
As a result, the NCD burden contributes 
most to perioperative mortality. The SASOS 
data also provide external validation of 
the importance of non-communicable risk 
factors for perioperative mortality.
Potential weaknesses of the study are 
that it only included 8/259 (3.1%) of the 
district hospitals in SA.[14] It is inappropriate 
to extrapolate the SASOS data to district 
hospitals, as although surgery may be 
limited in district hospitals, it is possible 
that the mortality is higher owing to limited 
resources, unmet surgical needs and a lack 
of provision for predominantly emergency 
surgery.[15] SASOS also only provides data 
from government-funded public sector 
hospitals in SA. It is possible that the burden 
of disease, case mix, prior health status, 
surgical techniques and outcomes may differ 
in the private sector hospitals.
Interpretation of the study
Based on the estimates of surgical volumes 
in SA by Weiser et al.,[1] the SA population 
statistics for 2013[16] and the SASOS data, the 
estimated mortality of surgery in adults (≥20 
years of age) in SA is between 76 and 128 
deaths per 100 000, which is equivalent to 
7.2% and 12.1% of all deaths in the country. 
It is inappropriate to directly compare the 
mortality rate between SASOS and EuSOS, 
as SASOS was censored at 30 days, and 
the SASOS patients had significantly fewer 
comorbidities that are established as risk 
factors for perioperative mortality. As the 
crude mortality rates for SASOS and EuSOS 
are similar, it is possible that a risk-adjusted 
mortality rate for surgery may be higher 
in SA.
SASOS suggests that the benefits 
associated with surgery[4] are compromised 
for a number of reasons. The contributing 
SA hospitals had on average fewer operating 
rooms and critical care beds than reported 
in EuSOS, even though the majority of 
the hospitals in SASOS were regional and 
tertiary hospitals. This may have contributed 
to the finding that over 50% of patients who 
died were not admitted to a critical care 
unit. The potential benefits of surgery were 
further compromised by predominantly 
urgent and emergency surgery, resulting in 
more unplanned critical care admissions, 
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Table 3. Critical care admission
No critical 
care 
admission
(N=3 672)
Any critical 
care 
admission
(N=255) OR† (95% CI) p-value
Planned 
critical care 
admission
(N=144)
Unplanned 
critical care 
admission 
(N=111) p-value
Age (years), mean (SD) 43.5 (17.7) 43.7 (16.7) 1.00 (0.99 - 1.01) 0.89 45.7 (17.0) 41.1 (15.9) 0.03
Male, n (%)* 1 835 (50.0) 159 (62.4) 1.66 (1.27 - 2.15) <0.001 84 (58.3) 75 (67.6) 0.15
Smoker, n (%) 1 015(28.2) 67 (28.5) 1.02 (0.76 - 1.36) 0.92 41 (30.4) 26 (26.0) 0.56
ASA category, n (%)
1 1 696 (46.6) 46 (18.1) Reference 21 (14.6) 25 (22.7) 0.07
2 1 300 (35.7) 47 (18.5) 1.34 (0.88 - 2.01) 0.17 31 (21.5) 16 (14.5)
3 561 (15.4) 102 (40.2) 6.70 (4.67 - 9.62) <0.001 62 (43.1) 40 (36.4)
4 78 (2.1) 53 (20.9) 25.05 (15.89 - 39.51) <0.001 29 (20.1) 24 (21.8)
5 8 (0.2) 6 (2.4) 27.65 (9.22 - 82.93) <0.001 1 (0.7) 5 (4.5)
Grade of surgery, n (%)
Minor 1 382 (38.0) 21 (8.4) Reference 10 (7.1) 11 (10.1) 0.13
Intermediate 1 596 (43.9) 76 (30.4) 3.13 (1.92 - 5.11) <0.001 37 (26.2) 39 (35.8)
Major 659 (18.1) 153 (61.2) 15.33 (9.62 - 24.41) <0.001 94 (66.7) 59 (54.1)
Urgency of surgery, n (%)
Elective 1 738 (47.5) 56 (22.1) Reference 43 (30.1) 13 (11.8) <0.001
Urgent 1 208 (33.0) 82 (32.4) 2.11 (1.49 - 2.98) <0.001 51 (35.7) 31 (28.2)
Emergency 715 (19.5) 115 (45.5) 4.99 (3.59 - 6.95) <0.001 49 (34.3) 66 (60.0)
Laparoscopic surgery, n (%) 150 (4.1) 8 (3.2) 0.78 (0.38 - 1.61) 0.50 5 (3.5) 3 (2.8) 0.74
Surgical specialty, n (%)
Orthopaedic 1 089 (29.7) 23 (9.1) 0.47 (0.26 - 0.85) 0.01 10 (7.0) 13 (11.7) 0.20
Breast 109 (3.0) 0 (0.0) 1.00 0 (0.0) 0 (0.0)
Gynaecology 515 (14.0) 10 (4.0) 0.43 (0.20 - 0.92) 0.03 3 (2.1) 7 (6.3) 0.09
Vascular 113 (3.1) 21 (8.3) 4.14 (2.2 - 7.79) <0.001 10 (7.0) 11 (9.9) 0.49
Upper GIT 122 (3.3) 32 (12.6) 5.84 (3.28 - 10.41) <0.001 15 (10.6) 17 (15.3) 0.26
Lower GIT 364 (9.9) 36 (14.2) 2.20 (1.27 - 3.81) 0.01 18 (12.7) 18 (16.2) 0.47
Hepatobiliary 80 (2.2) 8 (3.2) 2.23 (0.96 - 5.18) 0.06 5 (3.5) 3 (2.7) 0.73
Plastics 233 (6.4) 9 (3.6) 0.86 (0.39 - 1.90) 0.71 6 (4.2) 3 (2.7) 0.53
Urology 202 (5.5) 10 (4.0) 1.10 (0.51 - 2.37) 0.80 8 (5.6) 2 (1.8) 0.13
Kidney 12 (0.3) 1 (0.4) 1.86 (0.23 - 14.92) 0.56 1 (0.7) 0 (0.0) 0.38
Head and neck 203 (5.5) 19 (7.5) 2.09 (1.10 - 3.94) 0.02 13 (9.2) 6 (5.4) 0.34
Neurosurgery 88 (2.4) 45 (17.8) 11.39 (6.52 - 19.90) <0.001 32 (22.5) 13 (11.7) 0.03
Thoracic 48 (1.3) 17 (6.7) 7.89 (3.92 - 15.87) <0.001 14 (9.9) 3 (2.7) 0.04
Other 490 (13.4) 22 (8.7) Reference 7 (4.9) 15 (13.5) 0.02
Primary indication for surgery, n (%)
Non-communicable 1 775 (48.5) 105 (41.5) Reference 74 (52.1) 31 (27.9) <0.001
Injury 1 194 (32.6) 103 (40.7) 1.44 (1.09 - 1.92) 0.01 46 (32.4) 57 (51.4)
Infective 691 (18.9) 45 (17.8) 1.11 (0.78 - 1.60) 0.56 22 (15.5) 23 (20.7)
Comorbid disorder
Coronary artery disease 145 (4.0) 15 (6.1) 1.56 (0.90 - 2.71) 0.11 12 (8.7) 3 (2.8) 0.06
Congestive heart failure 47 (1.3) 8 (3.3) 2.57 (1.20 - 5.50) 0.02 5 (3.6) 3 (2.8) 0.72
Diabetes mellitus (no insulin) 209 (5.8) 16 (6.5) 1.14 (0.68 - 1.93) 0.62 8 (5.8) 8 (7.5) 0.61
Diabetes mellitus with insulin therapy 163 (4.5) 8 (3.3) 0.72 (0.35 - 1.48) 0.37 1 (0.7) 7 (6.5) 0.01
Continued ...
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an associated increased mortality, longer 
critical care stay, and therefore less critical 
care resources for patients. Urgency 
of surgery has a far larger proportional 
contribution to perioperative mortality than 
other preoperative surgical risk factors.
Importantly, the mortality and critical 
care admission rate associated with urgent 
and emergency surgery are mainly due to 
factors other than injuries and violence, as 
injuries have little or no contribution to the 
attributable risk in SASOS. The importance 
of the PAR is that it quantifies the proportion 
of cases that can be attributed to a risk 
factor,[13] which permits stratification of 
preventive public health interventions 
on the outcome. The majority of urgent 
and emergency surgery occurs across all 
surgical disciplines and comorbidities, and 
late presentation of patients for surgery 
in SA contributes significantly to surgical 
morbidity and mortality. This is important 
in strategic planning to provide safe surgery 
in SA.
The SASOS data suggest that NCDs have a 
larger proportional contribution to morbidity 
and mortality than infections and injuries. 
The contribution of NCDs to perioperative 
mortality in SA may be expected to increase 
as a result of epidemiological transition[17] 
and the success of HIV therapy in increasing 
life expectancy.[18]
The SASOS data suggest that the SA health 
budget needs to allocate more funding: (i) to 
primary healthcare to identify and manage 
potential surgical pathologies; and (ii) to 
hospital and tertiary healthcare services to 
provide sufficient surgical and critical care 
services to decrease surgical morbidity and 
mortality.
The need for urgent and emergency 
surgery may have arisen from a number 
of factors, including: (i) poor primary 
healthcare and late detection of surgical 
pathology; (ii) poor medical management of 
Table 3. (continued) Critical care admission
No critical 
care 
admission
(N=3 672)
Any critical 
care 
admission
(N=255) OR† (95% CI) p-value
Planned 
critical care 
admission
(N=144)
Unplanned 
critical care 
admission 
(N=111) p-value
Metastatic cancer 90 (2.5) 11 (4.5) 1.85 (0.97 - 3.50) 0.06 8 (5.8) 3 (2.8) 0.26
Cirrhosis 6 (0.2) 1 (0.4) 2.47 (0.30 - 20.60) 0.40 1 (0.7) 0 (0.0) 0.38
Stroke or TIA 50 (1.4) 5 (2.0) 1.49 (0.59 - 3.77) 0.40 1 (0.7) 4 (3.7) 0.10
COPD/asthma 212 (5.9) 28 (11.4) 2.08 (1.37 - 3.15) 0.001 19 (13.8) 9 (8.4) 0.23
HIV-positive/AIDS 489 (13.5) 20 (8.2) 0.57 (0.36 - 0.91) 0.02 11 (8.0) 9 (8.4) 1.00
GIT = gastrointestinal; TIA = transient ischaemic attack; COPD = chronic obstructive pulmonary disease.
*The denominators of the proportions are the number of cases that reported the risk factor.
†ORs were constructed for in-hospital mortality with univariate binary logistic regression analysis.
Table 4. Three-level generalised linear model for critical care admission
OR* (95% CI) p-value
PAR
% (95% CI)
Male 1.15 (0.81 - 1.65) 0.44
ASA category
1 Reference 26.1 (5.4 - 55.7)
2 1.78 (1.10 - 2.88) 0.02
3 5.87 (3.73 - 9.24) <0.001
4 13.82 (7.74 - 24.70) <0.001
5 7.18 (1.88 - 27.38) <0.001
Grade of surgery
Minor Reference 35.3 (9.5 - 70.8)
Intermediate 2.55 (1.47 - 4.42) 0.001
Major 10.93 (6.29 - 18.97) <0.001
Urgency of surgery
Elective Reference 23.7 (4.7 - 51.4)
Urgent 2.57 (1.65 - 3.99) <0.001
Emergency 3.19 (2.07 - 4.93) <0.001
Surgical specialty
Orthopaedic 0.25 (0.12 - 0.53) <0.001
Breast 1.00
Gynaecology 0.63 (0.26 - 1.54) 0.31
Vascular 0.91 (0.42 - 1.96) 0.80
Upper GIT 2.36 (1.18 - 4.73) 0.02 3.5 (0.4 - 8.6)
Lower GIT 1.17 (0.60 - 2.27) 0.65
Hepatobiliary 2.39 (0.87 - 6.59) 0.09
Plastics 1.10 (0.45 - 2.66) 0.84
Urology 1.28 (0.53 - 3.07) 0.58
Kidney 0.67 (0.07 - 6.36) 0.73
Head and neck 2.40 (1.13 - 5.12) 0.02 2.3 (0.4 - 5.1)
Neurosurgery 3.49 (1.75 - 6.98) <0.001 5.9 (0.7 - 13.9)
Thoracic 2.90 (1.20 - 7.05) 0.02 NS
Other Reference
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other comorbidities, with a negative impact 
on surgical outcomes; (iii) an inefficient 
surgical referral system; and (iv) insufficient 
surgical and critical care services, resulting 
in surgical operative delay. The data 
collected do not permit determination of the 
proportional contribution of these factors 
to urgent and emergency surgery, however, 
although the data did identify fewer surgical 
and critical care resources compared with 
Europe. It is also possible that the high 
proportion of urgent and emergency surgery 
may further contribute to increased mortality 
in SA patients. With a view to improving 
surgical outcomes, investigation of the 
contribution of the factors determining need 
for urgent/emergency surgery should be 
considered a public health priority.
Conclusion
In order to realise the full benefits of surgery 
in SA, it is important that a proactive 
strategy be adopted to increase surgical 
and critical care resources. Strategies aimed 
at decreasing the burden of urgent and 
emergent surgery should be implemented.
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Department of Anaesthesiology, Frere Hospital, East London, Eastern 
Cape, South Africa; B Mrara, FCA (SA), Head of Department, 
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Department, Department of Anaesthesiology, Charlotte Maxeke 
Johanesburg Academic Hospital, Johannesburg, South Africa; 
RESEARCH
474        June 2015, Vol. 105, No. 6
S S Pillay, LLM RCP&S (Irel), Head of Department, Department of 
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M Sebitloane, M Smith, S Spijkerman, M G L Spruyt, J Swanevelder, 
H van der Merwe, B L Warren, P H Wessels, on behalf of the SASOS 
investigators.
SASOS Steering Committee. B M Biccard, T E Madiba, R M Pearse, 
P Alexandris, D R Bhagwandass, K D Boffard, G A Buga, A Coetzee, 
A Daffala, B J Diedericks, R S du Toit, T M Esterhuizen, C Fourie, 
A Goolam Mohamed, P D Gopalan, F Guidozzi, R  W  Hewson, 
A Hoeft, I Joubert, D Kahn, H-L Kluyts, M Z Koto, B G Lindeque, 
A C Lundgren, R Machekano, L R Mathivha, T R Mokoena, 
S  Monokoane, R M R Moreno, D F Morrell, B Mrara, M Ntlhe, 
E E Oosthuizen, J P Pretorius, A Rantloane, A Rhodes, G A Richards, 
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Appendix 3. SASOS investigators and 
SASOS hospital sites
Eastern Cape Province. Cecilia Makiwane Hospital: K A Bhat*, 
B Dokolwana; Frere Hospital: M Coltman*, G Westcott; Livingstone 
Hospital: L Friedman, D Schmidt*, S Venter; Nelson Mandela 
Academic Hospital: A Dhaffala, B Mrara*, B Thomas, A Usenbo; 
Port Elizabeth Provincial Hospital: P Alexandris*, T Serdyn.
Free State Province. Dihlabeng Regional Hospital: W J Selfridge, 
A J Stals*, W van Zyl, J Vermaak; National Hospital, Pelonomi 
Regional Hospital and Universitas Academic Hospital: W Barret, 
M Bester, J de Beer, J Geldenhuys, H Gouws, J H Potgieter*, 
M Strydom, E Turton.
Gauteng Province. Charlotte Maxeke Johannesburg Academic 
Hospital: M Klipin, I Mare, V Morford*, O Smith; Chris Hani 
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E Patel, D Prem, R Pretorius, C Quan, T Ranyaka, K Rathinasamy, 
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Z Soni, J Steynberg, M Stubbs, O Tinubu, S Toich, S Tshukutsoane, 
J  Vally, A van der Walt, N van der Walt, E van Greunen, D van 
Niekerk, L Variawa, S Veeren, C von Creytz, J Wagner, J Yogeswaram; 
Dr George Mukhari Hospital: D R Bhagwandass, S L L K Dlamini, 
A Fourie, A Goolam Mahomed, J Joseph, N Kumar, T C Maganyane, 
M  Z Koto*, S R  Motilall; Helen Joseph Hospital: G Cavedon*, 
K  Fisher, H Jahrani, R Maja, J Malumalu, E Semenya, N Zondi; 
Kalafong Hospital: A Alberts, F Botha, J de Bruin, S Carrim, 
T Chagwiza, S East, P J H L Fourie, A Joubert, H Kluyts*, J Khosa, 
T Luvhengo, H Maakamedi, R Maharaj, S Motsitsi, J P Mulder, 
S Naidoo, H Schutte, A Vlok, M Voigt; Rahima Moosa Mother 
and Child Hospital: S Chetty*, M de Jager; Steve Biko Academic 
Hospital: Z Abdool, M Aphane, H J C du Plessis, P R Jujuju, 
E Moshokoa, M Ngcelwane, L M Ntlhe*, J P Pretorius, S Spijkerman, 
M Tshifilaro.
KwaZulu-Natal Province. Addington Hospital: M M F Ansermeah, 
A Dunpath, J Fabian, M Khan, M Maritz, M Naidoo, S Rambarran, 
P Reddy, U Singh*; Edendale Hospital: N Allorto, D Bishop*, 
P  M  Builu, C Cairns, A Dasrath, J de Wet, M den Hoedt, B  Grey, 
M Hayes, B Kusel, N Shangase, R Wise; Grey’s Hospital: S Cacala, 
Z Farina, V Govindasamy*, C-H Kruse, C Lee, L Marais, T D Naidoo, 
C Rajah, R Rodseth, L Ryan, R von Rhaden; King Dinuzulu 
Hospital: G Alexander, N Brouckaert, B Freeman*, S Goga; King 
Edward VII Hospital: R Chetty, S Chirkut, L Cronje*, K de 
Vasconcellos, N Z Dube, N S Gama, G Green, R Green Thompson, 
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S M Kinoo, P Kistnasami, K Maharaj, M S Moodley, S Mothae, 
R  Naidoo, A  Noorbhai, V Raghubar, J Reddy, A Singh, D Skinner, 
M Smith, B Singh; Inkosi Albert Luthuli Central Hospital: S Adam, 
C Alphonsus, Y Ameer, F Anderson, S Basanth, S Bechan, C Bhula, 
B M Biccard*, T Biyase, J Bruce, I Buccimazza, J Cardosa, C Y Chen, 
B Daya, L Drummond, A Elabib, E H Abdel Goad, I E Goga, R Goga, 
T C Hardcastle, R  Harrichandparsad, R E Hodgson, J  Jordaan, 
N  Kalafatis, C  Kampik, A T Landers, E Loots, R Madansein, 
A  Madaree, T E Madiba, V  T Manzini, M Mbuyisa, R Moodley, 
M  Msomi, D  J  J  Muckart, I  Mukama, D Naidoo, R Naidoo, 
T K Naidu, S Ntloko, E Padayachee, L Padayachee, M Phaff, B Pillay, 
D Pillay, L  Pillay, A  Ramnarain, S R Ramphal, P Ryan, A Saloojee, 
M Sebitloane, N Sigcu, J Taylor, A Torborg, L Visser; Ladysmith 
Hospital: I Asmal, M Gasa, G Madombwe*, S Mohanadasan; Lower 
Umfolozi District War Memorial Hospital: Y Bwambale*, N Mayat, 
L Mlambo-Williams; Madadeni and Newcastle hospitals: S Cheddie, 
A Elghobasy, R Hurley*, M Kopieniak, N M Naidoo; Mahatma Gandhi 
Hospital: M Ahmed, N Amod, M B Greenwood, B Hira, D Kesene, 
K Laubscher, D Naidoo, N A Mahomedy, S Moosa, V Moonsamy, 
S Reddy, D Rungan*, A S Sader, A Thotharam; Ngwelezane Hospital: 
R Misra, M Naidoo, Y Selibean, S Sewpersad*, S Sham, J Wessels; 
Northdale Hospital: K A Adu, J T Liphaphang, D Maiwaid*, 
M Marais, T Mniki; Port Shepstone Hospital: C Africander, T Bejia, 
S Blakemore*, M Botes, B Bunwarie, C B Hernandez, M A A Jeeraz, 
D Legutko, A Lopez, J de Meyer, T Muzenda, N Naidoo*, M Patel, 
H Pentela, M Junge, N Mansoor, L Rademan, P Scislowski, I Seedat, 
B van den Berg, D van der Merwe, S van Wyk; Prince Mshiyeni 
Hospital: K Govender*, D Naicker, R Ramjee, M Saley; R K Khan 
Hospital: A Ganesh, A Gounden, C Houston, S Mould, K Naidoo, 
A Nansook, N Rorke*, S Tarr; St Aidan’s Hospital: T Ramsamy; 
Stanger Hospital: W Kuhn, R Matos-Puig*, Z Moolla*.
Limpopo Province. Pietersburg Provincial Hospital: M A  Baloyi, 
L Bashiya, A Bogoslovskiy, M I Diale, N Escober, M E Gonzalez, 
D Horzstynski, P K Legodi, M E Maboya, R K Maila, A Z Machowski, 
M V Mashile, O R Masia, J N Masipa, M S L Masotja, R Mavhungu, 
M  S  Mokoena, T Mukwevho, S Z Mzezewa, E V Neluheni, 
D  S  Nesengani, S Omoding, L O Orjiako, N Perez, S S Pillay*, 
M Rambau, R Ramos, H Raura, B Ryabchiy, T O Sadiki, M D Seshibe, 
O S Taran, E N Thwala, B Woldu.
Mpumalanga Province. Rob Ferreira Hospital: C Chikwiri, 
C  A  Cumbi, M Dalton, N P Godi, S B Ibirogba, P R Jujuju*, 
N R Mahlalela, F A Steyn, A J Troskie, J Vosloo.
North West Province. Job Shimankana Tabane Hospital: T D Kibibi, 
A J M Lubamba, S J Moumakoe*, K Pege, W Seboni.
Northern Cape Province. Kimberley Hospital Complex: P Ander-
son, A Conradie, M de Swardt*, M de Villiers, J Eikman, R Liebenberg, 
J Mouton, A Paton, L van der Merwe, C Wilscott-Davids.
Western Cape Province. Eerste River Hospital: H Maharaj*, 
C Strauss; George Provincial Hospital: D Tait, M Jordaan*; Groote 
Schuur Hospital: K Bergh, M E Casey, E Cloete*, R Dyer, S Jeffrey, 
D Khan, W Makhambeni, D C Nolte, G Picken, J Swanevelder, D Visu; 
Helderberg and Karl Bremer hospitals: M Jaworska*; Khayelitsha 
District Hospital: H Lalkhen, H Maharaj*, S Serfontein; Mitchells 
Plain Hospital: T Biesman-Simons, S Carolissen, S Erasmus, J Holm, 
L Hoole, J Roos*, R Sauls, I Slabber, J van Schoor; Paarl Hospital: 
G Davies*, V Koller; Somerset Hospital: A Reed*, H Steinhaus; 
Tygerberg Hospital: I Conradie*, R Dannatt, M du Plessis, L du Preez, 
K du Toit, C Fourie, C Gildenhuys, A Gretschel, Y Loots, P Marwick, 
Y Ngcwama, R Rautenbach, P Scheepers, N Terblanche, F H van der 
Merwe, R van Rensburg, A Vermeulen, S Vlok, S Watcham; Victoria 
Hospital: N Fuller*; Worcester Hospital: W Christian, R Duvenage, 
T Franken, G Gobetz, W Hansen, T Kambarami*, M Kok, J Janse 
van Vuuren.
*Lead hospital investigator.
